Explore our latest news, case studies and tutorials
RNA-seq experiments rely on robust library prep stages to generate accurate and reliable transcriptomic data. Different library preparation technologies, such as Illumina TruSeq library prep…
MERCURIUS™ BRB-seq and DRUG-seq library preparations are now compatible with MGI sequencing. This gives researchers maximum flexibility to perform ultra-high-throughput 3’ mRNA-seq experiments where MGI…
The Library of Integrated Network-Based Cellular Signatures (LINCS) consortium from the National Institutes of Health (NIH) is a collective effort to catalog changes in gene…
L1000 is a high-throughput bead-based gene expression profiling assay that directly measures the mRNA abundance of 978 “landmark” genes selected to represent the diversity of…
In the current ocean of high-throughput sequencing techniques, it can be overwhelming to understand how a particular technology works, what it excels at, and what…
RASL-seq is a cost-effective, targeted, high-throughput sequencing technology developed to help researchers, biotechnology, and pharmaceutical companies streamline the discovery of potential therapeutics of tomorrow with…
RNA-mediated oligonucleotide Annealing, Selection, and Ligation with Next-Gen sequencing (RASL-seq) is a targeted high-throughput RNA-seq-based technology that has contributed to diverse biological discoveries from the…
Templated Oligo assay with Sequencing readout (TempO-Seq™) is a ligation-based targeted whole transcriptome expression profiling assay designed to maximize the utilization of precious or limited…
Determining the transcriptomic effects of novel compounds on cells for large-scale therapeutic or toxicology screens is a critical component of drug development pipelines, allowing researchers…
Clariom™ assays from Applied Biosystems™ use microarray technology to facilitate broad or targeted transcriptome analysis to identify crucial biomarkers, biological pathways, and complex gene expression…
Microarray-based Clariom™ assays from Applied Biosystems™ are a potential option for gene expression profiling studies when looking for a scalable technology to integrate into drug…
After almost thirty years since the first commercial prototype of the Affymetrix™ GeneChip™ microarray hit the market in 1994, its impact on our understanding of…
Tell us about your project and we will help you find the right approach.
